Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

被引：0
|
作者：
Keystone, Edward [1 ]
Landewe, Robert
van Vollenhoven, Ronald [2 ]
Combe, Bernard [3 ]
Strand, Vibeke [4 ]
Mease, Phillip [5 ,6 ]
Shaughnessy, Laura
VanLunen, Brenda
van der Heijde, Desiree [7 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Karolinska Inst, Stockholm, Sweden
[3] Hop Lapeyronie, F-34295 Montpellier, France
[4] Stanford Univ, Portola Valley, VA USA
[5] Swedish Med Ctr, Seattle, WA USA
[6] Univ Washington, Sch Med, Seattle, WA USA
[7] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24
引用
收藏
页码：1455 / 1456
页数：2
相关论文
共 50 条
  • [1] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 52-Week Randomized Controlled Trial and Open-Label Extension Study
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip J.
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S596 - S597
  • [2] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM A 52-WEEK RANDOMIZED CONTROLLED TRIAL AND OPEN-LABEL EXTENSION STUDY
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip J.
    Shaughnessy, Laura
    vanlunen, Brenda
    van der Heijde, Desiree
    [J]. RHEUMATOLOGY, 2014, 53 : 96 - 96
  • [3] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study
    Smolen, Josef S.
    van Vollenhoven, Ronald
    Kavanaugh, Arthur
    Strand, Vibeke
    Vencovsky, Jiri
    Schiff, Michael H.
    Landewe, Robert
    Haraoui, Boulos
    Walker, Susan
    van der Heijde, Desiree
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S988 - S989
  • [4] Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 24-Week Randomized Controlled Trial and Open-Label Extension Study
    Smolen, Josef
    Van Vollenhoven, Ronald
    Kavanaugh, Arthur
    Strand, Vibeke
    Vencovsky, Jiri
    Schiff, Michael
    Landewe, Robert
    Haraoui, Boulos
    Walker, Susan
    van der Heijde, Desiree
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1506 - 1507
  • [5] 5-YEAR RESULTS FROM THE RAPID 1 TRIAL AND OPEN-LABEL EXTENSION: LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Keystone, E.
    Landewe, R.
    van Vollenhoven, R.
    Combe, B.
    Strand, V.
    Mease, P. J.
    Shaughnessy, L.
    VanLunen, B.
    van der Heijde, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 228 - 229
  • [6] Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) : 2094 - 2100
  • [7] Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study
    Tanaka, Yoshiya
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    [J]. MODERN RHEUMATOLOGY, 2014, 24 (05) : 725 - 733
  • [8] Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study
    Tanaka, Yoshiya
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    [J]. MODERN RHEUMATOLOGY, 2014, 24 (05) : 734 - 743
  • [9] LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Alten, R.
    Davies, O.
    Stach, C.
    de Longueville, M.
    VanLunen, B.
    Choy, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 435 - 435
  • [10] Long-Term Safety and Efficacy of 4-Weekly Certolizumab Pegol Combination and Monotherapy in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
    Fleischmann, Roy M.
    van Vollenhoven, Ronald F.
    Vencovsky, Jiri
    Alten, Rieke
    Davies, Owen
    Stach, Christian
    de Longueville, Marc
    Van Lunen, Brenda
    Choy, Ernest
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S565 - S566
12345